The DTaP vaccine protects your child from diphtheria, tetanus, and pertussis (also known as whooping cough). DTaP is shorthand for this vaccine. It's a routine vaccine for all children starting at 2 months of age and given as a 5-dose series (1 injection at age 2 months, 4 months, 6 months, 15 to 20 months, and 4 to 6 years). Children older than 7 years of age and adults who didn't receive or complete the DTaP vaccine series receive the Tdap vaccine instead of the DTaP vaccine. Common side effects include injection-site reactions, sleepiness, and irritability.
Prevention of:
Diphtheria
Tetanus
Pertussis (whooping cough)
The DTaP vaccine is an inactivated vaccine that protects you from three bacteria that cause different conditions: Corynebacterium diphtheriae (diphtheria), Clostridium tetani (tetanus), and Bordetella pertussis (pertussis or whooping cough). The vaccine helps your body's immune system make antibodies that will attack these bacteria if they ever infect you.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Works well to prevent diphtheria, tetanus, and whooping cough
Can be given with other vaccines
Readily available and easy to find
Can be given to children as young as 6 weeks old
Needs to be injected into the muscle
Must be given by a healthcare provider at an office, clinic, or pharmacy
Need to receive 5 injections to complete the series
Not used in people age 7 years and older
Read the vaccine information statement for more information on the DTaP vaccine.
If your child has a brain condition, talk to your child's provider before they receive the DTaP vaccine to make sure it's right for them. Your child's provider might hold off on giving your child the vaccine because there can be confusion between the rare side effects of the DTaP vaccine and the signs or symptoms of your child's brain condition.
Wait until your child is healthy to get the DTaP vaccine. This will help make sure their immune system protects them as best as it can. If your child has a mild sickness, such as a cold or low-grade fever, they can still get the DTaP vaccine. But if your child feels moderately to severely sick, wait until they recover. Ask your child's provider if you're not sure whether they can get this vaccine.
Most children who receive the DTaP vaccine don't have any serious side effects. Side effects are generally mild and should go away on their own in a few days.
If your child has a history of seizures, ask your child's provider about medication to prevent a high fever from occuring after getting the DTaP vaccine.
Make sure to keep a record of all your child's immunizations and show it to your child's provider or pharmacist before they receive any vaccines, including the DTaP vaccine, to make sure they're receiving all their vaccines on schedule.
If your child experiences a severe reaction to the DTaP vaccine, you or your child's provider can report it to the vaccine adverse event reporting system (VAERS) website or call this reporting system at 1-800-822-7967.
The DTaP vaccine can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Latex allergy (for Infanrix only) | Allergic reaction to other vaccines
As with any vaccine, there's a rare chance that your child might have a severe allergic reaction to the DTaP vaccine. The risk is higher if your child is allergic to latex and receives Infanrix, since tip caps of the prefilled syringes contain natural rubber latex. Your provider might ask you and your child to stay at the pharmacy or clinic for a short period of time after your child has received the vaccine to make sure your child can get proper care in case of a serious allergic reaction. Sometimes, these reactions can happen after you've already left the clinic. Get medical help right away if you notice symptoms of a severe allergic reaction, such as feeling faint, swelling of the face, closing of the throat, difficulty breathing, hives or rash, dizziness, shaking, nausea, or chest pain.
Risk factors: Fainting after vaccines in the past
Fainting can happen while or after receiving injectable vaccines, such as the DTaP vaccine. Signs of fainting include changes in vision, burning sensation, and stiffening or twitching of your arms and legs. Let your child's provider know if your child has fainted after vaccines in the past so they can be monitored.
Risk factors: Medical conditions or medications that weaken the immune system
The DTaP vaccine might not work as well in children with a weakened immune system. This can put your child at higher risk of diphtheria, tetanus, and whooping cough, even after they've received the vaccine. If your child has any medical conditions (e.g., HIV (human immunodeficiency virus), cancer) or takes medications that weaken their immune system (e.g., high-dose corticosteroids,transplant medications), talk to your child's provider before they receive the DTaP vaccine.
Risk factors: Previous side effects from another pertussis vaccine
Before your child receives the DTaP vaccine, tell your child's provider or pharmacist if your child has ever had side effects within 2 to 3 days after receiving a pertussis vaccine. These side effects include a high fever (105 degrees Fahrenheit or more), collapsing or passing out, continuous crying lasting at least 3 hours, or seizures with or without a fever. Your child's provider or pharmacist will weigh the risks and benefits of your child receiving another pertussis-containing vaccine like the DTaP vaccine.
Risk factors: Premature birth
Babies who were born prematurely have experienced apnea after receiving vaccines that are injected into the muscle, like the DTaP vaccine. Apnea is a condition where there's a temporary pause in their breathing, sometimes occurring with a slowed heart rate or low oxygen level. If your baby was born prematurely, be sure to discuss the benefits and risks of receiving the DTaP vaccine with your child's provider.
Risk factors: GBS within 6 weeks of receiving any tetanus vaccine
Although very rare, some people have reported getting GBS or nerve problems after they've received tetanus toxoid-containing vaccines like the DTaP vaccine. GBS is a rare condition that causes muscle weakness and paralysis. Let your child's provider know right away if your child has experienced these symptoms, especially if it occurred within 6 weeks of receiving a tetanus toxoid-containing vaccine.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
0.5ml | 1 vial | $75.01 | $75.01 |
The DTaP vaccine is given as an injection into the thigh muscle (for babies up to 1 year of age) or shoulder muscle (for children older than 1 year of age) by a healthcare provider. There are two DTaP vaccines available: Daptacel and Infanrix.
Routine vaccination: This vaccine is typically a 5-dose series, given as 1 injection at age 2 months, 4 months, 6 months, 15 to 20 months, and 4 to 6 years.
Note: Please see FAQs for more details about the following.
The CDC includes specific recommendations for vaccination in children who get wounds.
The immunization schedule in children for catch-up vaccination and certain special situations might differ.
Severe allergy to any diphtheria, tetanus, or pertussis-containing vaccine (including DT, Td, and DTaP)
Coma, have seizures for a long time, or lowered level of consciousness within 7 days of a previous dose of a pertussis-containing vaccine
Certain brain disorders (e.g., uncontrolled seizures)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2021). DTaP (diphtheria, tetanus, pertussis) VIS.
Centers for Disease Control and Prevention. (2022). About diphtheria, tetanus, and pertussis vaccines.
Centers for Disease Control and Prevention. (2022). Adjuvants and vaccines.
Centers for Disease Control and Prevention. (2022). Diphtheria, tetanus, and whooping cough vaccination.
Centers for Disease Control and Prevention. (2022). Diphtheria.
Centers for Disease Control and Prevention. (2022). Pertussis (whooping cough).
Centers for Disease Control and Prevention. (2022). Tetanus.
Centers for Disease Control and Prevention. (2023). About the Vaccines for Children program (VFC).
Centers for Disease Control and Prevention. (2023). ACIP recommendations.
Centers for Disease Control and Prevention. (2023). Adult immunization schedule by age.
Centers for Disease Control and Prevention. (2023). Child and adolescent immunization schedule by age.
Centers for Disease Control and Prevention. (2023). Diphtheria, tetanus, and pertussis vaccine recommendations.
Centers for Disease Control and Prevention. (2023). Vaccines for Children (VFC) program information for awardees.
GlaxoSmithKline Biologicals SA. (2023). Infanrix- diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed suspension [package insert]. DailyMed.
Kondamudi, N. P., et al. (2023). Apnea in children. StatPearls.
U.S. Food and Drug Administration. (2018). Thimerosal and vaccines.
World Health Organization. (2020). How do vaccines work?
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.